XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:            
Research and development $ 8,262,167   $ 4,033,963   $ 16,048,223 $ 6,183,604
General and administrative 1,497,533   1,938,447   3,681,193 5,042,518
Total operating expenses 9,759,700   5,972,410   19,729,416 11,226,122
Operating loss (9,759,700)   (5,972,410)   (19,729,416) (11,226,122)
Other income:            
Interest income, net 222,578   36,024   455,113 55,673
Total other income 222,578   36,024   455,113 55,673
Loss before income taxes (9,537,122)   (5,936,386)   (19,274,303) (11,170,449)
Income tax expense (benefit) 0   0   0 0
Net loss $ (9,537,122) $ (9,737,181) $ (5,936,386) $ (5,234,063) $ (19,274,303) $ (11,170,449)
Basic loss per common share $ (1.07)   $ (0.73)   $ (2.25) $ (1.37)
Diluted loss per common share $ (1.07)   $ (0.73)   $ (2.25) $ (1.37)
Weighted average number of common shares outstanding, basic 8,951,309   8,163,923   8,575,239 8,160,702
Weighted average number of common shares outstanding, diluted 8,951,309   8,163,923   8,575,239 8,160,702